| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,284 |
9,786 |
$521K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
12,126 |
10,722 |
$354K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,560 |
8,101 |
$303K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
3,770 |
3,449 |
$278K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
12,678 |
5,745 |
$105K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,220 |
1,122 |
$61K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,446 |
3,017 |
$24K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,241 |
1,016 |
$12K |
| 87807 |
|
89 |
81 |
$579.27 |
| 81003 |
|
145 |
123 |
$337.01 |
| 86318 |
|
12 |
12 |
$161.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
417 |
374 |
$155.91 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
29 |
28 |
$90.06 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
52 |
36 |
$44.73 |
| 86308 |
|
12 |
12 |
$44.19 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15 |
13 |
$19.96 |